374 related articles for article (PubMed ID: 9797906)
1. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men.
Barger-Lux MJ; Heaney RP; Dowell S; Chen TC; Holick MF
Osteoporos Int; 1998; 8(3):222-30. PubMed ID: 9797906
[TBL] [Abstract][Full Text] [Related]
2. Dose-response effects of supplementation with calcifediol on serum 25-hydroxyvitamin D status and its metabolites: A randomized controlled trial in older adults.
Vaes AMM; Tieland M; de Regt MF; Wittwer J; van Loon LJC; de Groot LCPGM
Clin Nutr; 2018 Jun; 37(3):808-814. PubMed ID: 28433267
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D3 supplementation: Response and predictors of vitamin D3 metabolites - A randomized controlled trial.
Lehmann U; Riedel A; Hirche F; Brandsch C; Girndt M; Ulrich C; Seibert E; Henning C; Glomb MA; Dierkes J; Stangl GI
Clin Nutr; 2016 Apr; 35(2):351-358. PubMed ID: 26037521
[TBL] [Abstract][Full Text] [Related]
5. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
Mortensen BM; Gautvik KM; Gordeladze JO
Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
[TBL] [Abstract][Full Text] [Related]
6. The effect of different vitamin D treatments on serum vitamin D levels in early postmenopausal women.
Riis B; Christiansen C; Rodbro P
Acta Vitaminol Enzymol; 1984; 6(2):77-82. PubMed ID: 6093487
[TBL] [Abstract][Full Text] [Related]
7. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
Leventis P; Kiely PD
Scand J Rheumatol; 2009; 38(2):149-53. PubMed ID: 18991184
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D Metabolites and Their Association with Calcium, Phosphorus, and PTH Concentrations, Severity of Illness, and Mortality in Hospitalized Equine Neonates.
Kamr AM; Dembek KA; Reed SM; Slovis NM; Zaghawa AA; Rosol TJ; Toribio RE
PLoS One; 2015; 10(6):e0127684. PubMed ID: 26046642
[TBL] [Abstract][Full Text] [Related]
9. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
[TBL] [Abstract][Full Text] [Related]
10. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D-deficiency in the elderly: treatment with ergocalciferol and hydroxylated analogues of vitamin D3.
Shany S; Chaimovitz C; Yagev R; Bercovich M; Lowenthal MN
Isr J Med Sci; 1988 Mar; 24(3):160-3. PubMed ID: 3259568
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D metabolites in diabetic patients: decreased serum concentration of 24,25-dihydroxyvitamin D.
Christiansen C; Christensen MS; McNair P; Nielsen B; Madsbad S
Scand J Clin Lab Invest; 1982 Oct; 42(6):487-91. PubMed ID: 6760373
[TBL] [Abstract][Full Text] [Related]
13. Increased catabolism of 25-hydroxyvitamin D in patients with partial gastrectomy and elevated 1,25-dihydroxyvitamin D levels. Implications for metabolic bone disease.
Davies M; Heys SE; Selby PL; Berry JL; Mawer EB
J Clin Endocrinol Metab; 1997 Jan; 82(1):209-12. PubMed ID: 8989260
[TBL] [Abstract][Full Text] [Related]
14. Estimation of the maternal vitamin D intake that maintains circulating 25-hydroxyvitamin D in late gestation at a concentration sufficient to keep umbilical cord sera ≥25-30 nmol/L: a dose-response, double-blind, randomized placebo-controlled trial in pregnant women at northern latitude.
O'Callaghan KM; Hennessy Á; Hull GLJ; Healy K; Ritz C; Kenny LC; Cashman KD; Kiely ME
Am J Clin Nutr; 2018 Jul; 108(1):77-91. PubMed ID: 29878035
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of increasing wintertime vitamin D and calcium intake by milk fortification.
McKenna MJ; Freaney R; Byrne P; McBrinn Y; Murray B; Kelly M; Donne B; O'Brien M
QJM; 1995 Dec; 88(12):895-8. PubMed ID: 8593549
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
Magliola L; Anast CS; Forte LR
Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783
[TBL] [Abstract][Full Text] [Related]
17. Abnormalities of parathyroid hormone secretion in elderly women that are reversible by short term therapy with 1,25-dihydroxyvitamin D3.
Ledger GA; Burritt MF; Kao PC; O'Fallon WM; Riggs BL; Khosla S
J Clin Endocrinol Metab; 1994 Jul; 79(1):211-6. PubMed ID: 8027229
[TBL] [Abstract][Full Text] [Related]
18. Effects of vitamin D3 supplementation and UVb exposure on the growth and plasma concentration of vitamin D3 metabolites in juvenile bearded dragons (Pogona vitticeps).
Oonincx DG; Stevens Y; van den Borne JJ; van Leeuwen JP; Hendriks WH
Comp Biochem Physiol B Biochem Mol Biol; 2010 Jun; 156(2):122-8. PubMed ID: 20206712
[TBL] [Abstract][Full Text] [Related]
19. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D3 metabolites in chronic renal failure and after renal transplantation.
Lucas PA; Woodhead JS; Brown RC
Nephrol Dial Transplant; 1988; 3(1):70-6. PubMed ID: 3132643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
